After pioneering studies of Al-Hajj et al. [28] in human breast cancer, CD44+/CD24−/low cells were recognized as prospective cancer stem cells for basal/mesenchymal cell lines MCF 7 and MDA-MB-231. Here, CD44 is linked to cancer.